Litigation Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (D. Del. 2023)
✉ Email this page to a colleague
United Therapeutics Corporation v. Liquidia Technologies, Inc. (D. Del. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-09-05 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | Sherry R. Fallon |
| Patents | 7,417,070; 7,544,713; 8,497,393; 9,339,507; 9,358,240; 9,593,066; 9,604,901 | ||
| Link to Docket | External link to docket | ||
Details for United Therapeutics Corporation v. Liquidia Technologies, Inc. (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-04-19 | 71 | Redacted Document | and Device Mouthpiece Shape on Bolus 7,417,070 B2 8/2008 Phares et al. …later-listed patent, U.S. Patent No. 10,716,793 (“the ’793 patent”), but because that patent was later- … Decision • U.S. Patent numbers: Patent 9,604,901, Patents 9,593,066, Patent 10,716,793 • Under Hatch-Waxman…]. US Patent No. 5,153,222 US Patent No. 6,765,117 US Patent No. 6,521,212 US Patent No. 6,756,…both the '327 patent 8 patent? 9 and the '793 patent describe the use of | External link to document |
| 2024-05-23 | 94 | Claim Construction Chart | 9,339,507 …Construction Chart (Ex. A) for U.S. Patent No. 11,826,327 (“the ’327 patent”) (Ex. B). Exhibit A includes…adverse ’327 Patent Prosecution indefiniteness under § ʼ327 patent at: … is into ’327 patent by Liquidia’s device does ʼ327 patent: … claims into ’327 patent by ʼ327 patent: | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
